Novatio Ventures
Novatio Ventures is a venture capital firm focused on life sciences, investing in seed, early-stage and spin-off opportunities. It backs therapeutics, diagnostics, devices and drug delivery technologies and aims to accelerate the commercialization of innovations. The firm collaborates with inventors, entrepreneurs and research institutions to develop development plans, assemble management teams and secure follow-on capital, seeking outsized, risk-mitigated value through early exits. With a global network and operating experience, Novatio leverages cross-border opportunities to support portfolio companies. The firm is based in Toronto and maintains additional offices in Cambridge, Boston and Hong Kong, reflecting its international reach and emphasis on regions with strong life sciences ecosystems.
Top Regions
Top Stages
1 past transactions
WinterLight Labs
Seed Round in 2017
WinterLight Labs Inc. is a Toronto-based company founded in 2015 that specializes in developing a speech-based platform for the detection and monitoring of cognitive and mental diseases, including dementia and Alzheimer's disease. The company's innovative AI technology analyzes natural speech samples to quantify various speech and language patterns, enabling the accurate assessment of cognitive health. By utilizing a brief one-minute speech sample, WinterLight's platform can characterize aspects such as lexical diversity, syntactic complexity, semantic content, and articulation, effectively capturing the speaker's cognitive state. This diagnostic tool has significant applications across clinical trials, long-term care, primary care, and speech-language pathology, facilitating the early detection of cognitive impairment and tracking disease progression.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.